ESTA Establishment Labs Holdings Inc.
USHealthcareAs of 2026-07-09 16:00
Why ESTA matters now
Establishment Labs Holdings Inc. (ESTA) is a US stock in Healthcare. The latest InvestLog snapshot shows $88.77 with +0.89% on the session and $2.61B in market capitalization; recent performance reads 1-month +29.38% and YTD +16.37%.
The latest financial table shown here is Q1 2026, with revenue of $59.9M, net income of $-13.4M, and EPS of $-0.45. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -1.7%.
The latest indexable market news headline is "A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction." from The Motley Fool.
Additional event context on this page matters because analyst consensus is Buy with a median target of $86.00; recent insider activity includes JW Asset Management, LLC filing S-Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
169.94
P/S
10.87
EV/EBITDA
-187.15
DCF Value
$-75.49
FCF Yield
-1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
70.1%
Operating Margin
-12.4%
Net Margin
-19.1%
ROE
-225.9%
ROA
-12.5%
ROIC
-8.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $59.9M | $-13.4M | $-0.45 |
| Q4 2025 | $64.6M | $-2.6M | $-0.09 |
| FY 2025 | $211.1M | $-51.1M | $-1.72 |
| Q3 2025 | $53.8M | $-11.1M | $-0.38 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$86.00
Target (Median)
$86.00
Target Range
$86.00 - $86.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
CR
Exchange
—
Beta
1.11
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.